Clinical pediatric positron emission tomography/magnetic resonance program: a guide to successful implementation

Children with malignancies undergo recurrent imaging as part of tumor diagnosis, staging and therapy response assessment. Simultaneous positron emission tomography (PET) and magnetic resonance (MR) allows for decreased radiation exposure and acts as a one-stop shop for disease in which MR imaging is...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric radiology 2020-05, Vol.50 (5), p.607-617
Main Authors: Saade-Lemus, Sandra, Nevo, Elad, Soliman, Iman, Otero, Hansel J., Magee, Ralph W., Drum, Elizabeth T., States, Lisa J.
Format: Article
Language:English
Subjects:
Child
Computed tomography
Emission analysis
Humans
Imaging
Magnetic resonance imaging
Magnetic Resonance Imaging - methods
Medical imaging
Medicine
Medicine & Public Health
Multimodal Imaging - methods
Neuroradiology
Nuclear Medicine
Oncology
Pediatrics
Pediatrics - methods
Positron emission
Positron emission tomography
Positron-Emission Tomography - methods
Radiation effects
Radiology
Review
Scanners
Tomography
Ultrasound
Workflow
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Children with malignancies undergo recurrent imaging as part of tumor diagnosis, staging and therapy response assessment. Simultaneous positron emission tomography (PET) and magnetic resonance (MR) allows for decreased radiation exposure and acts as a one-stop shop for disease in which MR imaging is required. Nevertheless, PET/MR is still less readily available than PET/CT across institutions. This article serves as a guide to successful implementation of a clinical pediatric PET/MR program based on our extensive clinical experience. Challenges include making scanners more affordable and increasing patient throughput by decreasing total scan time. With improvements in workflow and robust acquisition protocols, PET/MR imaging is expected to play an increasingly important role in pediatric oncology.
ISSN:0301-0449
1432-1998
DOI:10.1007/s00247-019-04578-z